NCT04217018View on ClinicalTrials.gov

MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 1, 2027

Study Completion Date

June 1, 2027

Conditions
Glioma
Interventions
DIAGNOSTIC_TEST

Prediction of molecular pathology

Prediction of 1p/19q co-deletion, MGMT methylation, IDH and TERTp mutations or molecular subgroups by leveraging AI

Trial Locations (1)

450052

RECRUITING

Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
collaborator

Sun Yat-sen University

OTHER

lead

The First Affiliated Hospital of Zhengzhou University

OTHER